ID CORE XT
Report
- Report Number
- 3006413195-2020-00019
- Event Type
- Malfunction
- Date Received
- September 23, 2020
- Date of Event
- July 27, 2020
- Report Date
- September 23, 2020
- Manufacturer
- PROGENIKA BIOPHARMA S.A.
- Product Code
- PEP
- PMA / PMN Number
- BP170154
- Removal / Correction Number
- N/A
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KU
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THE GENOMIC DNA SAMPLE WAS SENT TO GRIFOLS IH CENTER FOR BI-DIRECTIONAL SEQUENCING. SEQUENCING INTERROGATED JK GENE EXONS 3 TO 10 AND THE GENOTYPE JK*B(588G,956T) HOMOZYGOUS WAS IDENTIFIED. THE ALLELE JK*B(956T) IS A NULL ALLELE REPORTED BY ISBT, JK*02N.08. HENCE, THE GENOTYPE RESULT JK*B(588G,956T) HOMOZYGOUS WITH A PREDICTED JKB- PHENOTYPE IS IN CONCORDANCE WITH THE SEROLOGY RESULT, JKB-. ID CORE XT REPORTED A PREDICTED JKB+ PHENOTYPE, BUT JK*B(956T) NULL ALLELE, NOT INTERROGATED BY ID CORE XT, IS FOUND ASSOCIATED WITH A JKB- PHENOTYPE. THIS FALSE POSITIVE RESULT OBTAINED BY ID CORE XT IS CONSIDERED A DISCREPANT RESULT AND THEN A MALFUNCTION. THIS LIMITATION IS COVERED BY THE GENERAL ASSAY LIMITATIONS DESCRIBED IN THE ID CORE XT PACKAGE INSERT (LIMITATIONS 1 AND 10).
THE CUSTOMER REPORTED A POSSIBLE DISCREPANCY. THE SEROLOGICAL PHENOTYPE WAS JKB- AND THE ID CORE XT GENOTYPE SUGGESTED A PHENOTYPE OF JKB+.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1042187 | ID CORE XT | ID CORE XT | PEP | PROGENIKA BIOPHARMA S.A. | 1020220034 | 0203000018 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |